Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Cindy Delbrook"'
Autor:
Kenneth Cornetta, Lisa Duffy, Steven A. Feldman, Crystal L. Mackall, Marco L. Davila, Kevin J. Curran, Richard P. Junghans, Jean Yuh Tang, James N. Kochenderfer, Roisin O’Cearbhaill, Gary Archer, Hans-Peter Kiem, Nirali N. Shah, Cindy Delbrook, Rosie Kaplan, Renier J. Brentjens, Isabelle Rivière, Michel Sadelain, Steven A. Rosenberg
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 10, Iss , Pp 371-378 (2018)
Replication-competent retrovirus (RCR) is a safety concern for individuals treated with retroviral gene therapy. RCR detection assays are used to detect RCR in manufactured vector, transduced cell products infused into research subjects, and in the r
Externí odkaz:
https://doaj.org/article/d41ec9a65e514c438579bc848efe4243
Autor:
Vandana Sachdev, Amita Kulshreshtha, Julia W Cohen, Doug R Rosing, Stanislav Sidenko, Cindy Delbrook, Brandon Wiley
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Chimeric antigen receptor (CAR) T-cell-associated cytokine release syndrome (CRS) may present with tachycardia, hemodynamic instability and reduced cardiac function. Pediatric CAR studies examining cardiac toxicity are limited.Methods We r
Externí odkaz:
https://doaj.org/article/bd2b97bd87de45fa847e89470db39128
Autor:
Vandana Sachdev, Amita Kulshreshtha, Julia W Cohen, Doug R Rosing, Stanislav Sidenko, Cindy Delbrook, Brandon Wiley
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Externí odkaz:
https://doaj.org/article/68a49cba8d0f4ed9ab75c36f0595db27
Autor:
Haneen Shalabi, Ira L. Kraft, Hao-Wei Wang, Constance M. Yuan, Bonnie Yates, Cindy Delbrook, Julie D. Zimbelman, Roger Giller, Maryalice Stetler-Stevenson, Elaine S. Jaffe, Daniel W. Lee, Jack F. Shern, Terry J. Fry, Nirali N. Shah
Publikováno v:
Haematologica, Vol 103, Iss 5 (2018)
Externí odkaz:
https://doaj.org/article/5947d89af3e04946b0efe5f29738eaf6
Autor:
Crystal L. Mackall, Howard Streicher, Jedd D. Wolchok, Rachel Bishop, Maya Lodish, Cindy Delbrook, Donna Bernstein, Carlos Rodriguez-Galindo, Leonard H. Wexler, Kristin Baird, Matthew Wright, Melinda S. Merchant
Absolute numbers of CD3+ and CD4+ HLA-DR+ activated T cells increase at day 21 and day 42 following ipilimumab infusion.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f31e88646c1faf0dadfa6c7abdd5333
https://doi.org/10.1158/1078-0432.22459578
https://doi.org/10.1158/1078-0432.22459578
Autor:
Crystal L. Mackall, Howard Streicher, Jedd D. Wolchok, Rachel Bishop, Maya Lodish, Cindy Delbrook, Donna Bernstein, Carlos Rodriguez-Galindo, Leonard H. Wexler, Kristin Baird, Matthew Wright, Melinda S. Merchant
Purpose: Ipilimumab is a first-in-class immune checkpoint inhibitor approved for treatment of metastatic melanoma but not studied in children until this phase I protocol.Experimental Design: This study examined safety, pharmacokinetics, and immunogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d91f2e7b03e2c507370baa54370d861
https://doi.org/10.1158/1078-0432.c.6524250.v1
https://doi.org/10.1158/1078-0432.c.6524250.v1
Autor:
David F. Stroncek, Pamela L. Wolters, Terry J. Fry, Maryalice Stetler-Stevenson, Haneen Shalabi, Cindy Delbrook, Crystal L. Mackall, Staci Martin, Nirali N. Shah, Daniel W. Lee, Eva H. Baker, Seth M. Steinberg, Bonnie Yates, Constance M. Yuan
Publikováno v:
J Clin Oncol
PURPOSE CD19 chimeric antigen receptor (CD19-CAR) T cells induce high response rates in children and young adults (CAYAs) with B-cell acute lymphoblastic leukemia (B-ALL), but relapse rates are high. The role for allogeneic hematopoietic stem-cell tr
Autor:
Staci Martin, Maryalice Stetler-Stevenson, Sandhya R. Panch, Seth M. Steinberg, Steven L. Highfill, Haris Qureshi, Cindy Delbrook, Haiying Qin, Alina Dulau-Florea, Hao-Wei Wang, Crystal L. Mackall, Jianjian Jin, Constance M. Yuan, Lauren Little, Pamela L. Wolters, David F. Stroncek, Haneen Shalabi, Leah Hoffman, Dalia Salem, Terry J. Fry, Nirali N. Shah, Anusha Ponduri, Minh Tran, Bonnie Yates, Amanda K. Ombrello
Publikováno v:
J Clin Oncol
PURPOSE Patients with B-cell acute lymphoblastic leukemia who experience relapse after or are resistant to CD19-targeted immunotherapies have limited treatment options. Targeting CD22, an alternative B-cell antigen, represents an alternate strategy.
Autor:
Cindy Delbrook, Haneen Shalabi, Bonnie Yates, Dalia Salem, Diane Libert, Maryalice Stetler-Stevenson, Katherine E. Masih, Javed Khan, Jack F. Shern, Pallavi Galera, Terry J. Fry, Nirali N. Shah, Constance M. Yuan
Publikováno v:
Leukemia
Autor:
Kevin J. Curran, Nirali N. Shah, Steven A. Rosenberg, Marco L. Davila, Roisin E. O'Cearbhaill, Gary E. Archer, Jean Yuh Tang, Crystal L. Mackall, Richard P. Junghans, Michel Sadelain, Lisa Duffy, Kenneth Cornetta, Renier J. Brentjens, Rosie Kaplan, Hans-Peter Kiem, Steven A. Feldman, Isabelle Riviere, Cindy Delbrook, James N. Kochenderfer
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 10, Iss, Pp 371-378 (2018)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
Replication-competent retrovirus (RCR) is a safety concern for individuals treated with retroviral gene therapy. RCR detection assays are used to detect RCR in manufactured vector, transduced cell products infused into research subjects, and in the r